Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 15, 2025
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
GlobeNewswire
·
April 15, 2025
Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s pipeline diversification beyond BNC210 US $15M milestone payment from Merck extends company’s cash runway to …
Basetwo Wins Top Prize at CIX Summit 2025, Selected for Startup World Cup
GlobeNewswire
·
April 15, 2025
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Basetwo, an AI platform for manufacturing, has been recognized at the 2025 CIX Summit as the 2025 Canadian Regional Winner, positioning itself to represent Canada at the upcoming Startup World Cup in Silicon …
Alberta Cancer Foundation partners with CDL Cancer to advance oncology innovation
GlobeNewswire
·
April 15, 2025
CALGARY, Alberta, April 15, 2025 (GLOBE NEWSWIRE) -- Creative Destruction Lab (CDL) is pleased to announce that the Alberta Cancer Foundation (ACF) is joining the CDL Cancer program. This partnership brings together a shared commitment to accelerate the …
First Onsite Pensacola Expands Biohazard Response Capabilities
GlobeNewswire
·
April 15, 2025
PENSACOLA, Fla., April 15, 2025 (GLOBE NEWSWIRE) -- First Onsite Property Restoration (First Onsite), one of North America’s largest disaster recovery and restoration providers for commercial enterprises, today announced a major expansion of its biohazard …
Lisata Therapeutics Announces Research License with Catalent
GlobeNewswire
·
April 15, 2025
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
IPG Photonics to Announce First Quarter 2025 Financial Results on May 6
GlobeNewswire
·
April 15, 2025
MARLBOROUGH, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The Company will hold a conference call to review these …
Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir
GlobeNewswire
·
April 15, 2025
FREEHOLD, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, today announced the addition of …
Rezolve Ai Secures $9.8 Million Annual Contract with Liverpool Mexico
GlobeNewswire
·
April 15, 2025
NEW YORK and MEXICO CITY, April 15, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, is proud to announce a landmark $9.8 million yearly contract with Liverpool Mexico, the country’s premier department …
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
GlobeNewswire
·
April 15, 2025
In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …
Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions
GlobeNewswire
·
April 15, 2025
SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Pipe, a fintech company enabling embedded financial solutions for software platforms, today announced its strategic acquisition of Glean.ai, a leading AI-powered spend management company. With this …
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
GlobeNewswire
·
April 15, 2025
HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …
LyondellBasell baut seine Führungsrolle im Bereich Nachhaltigkeit im Nachhaltigkeitsbericht 2024 aus: From Vision to Value (Von der Vision zum Wert)
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), ein weltweit führendes Unternehmen der chemischen Industrie, hat heute seinen Nachhaltigkeitsbericht 2024 veröffentlicht, in dem bedeutende Fortschritte bei zirkulären und …
LyondellBasell promueve el liderazgo en sostenibilidad en el Informe de Sostenibilidad 2024: De la visión al valor
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), un líder mundial en el sector de química, publicó hoy su Informe de Sostenibilidad 2024, que muestra un progreso significativo en soluciones circulares y bajas en carbono, acción …
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
GlobeNewswire
·
April 15, 2025
SOUTH SAN FRANCISCO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
Combating Document Fraud and Transnational Crime: Lao PDR Airport Deploys Regula 4306 Comparator
GlobeNewswire
·
April 15, 2025
RESTON, Va., April 15, 2025 (GLOBE NEWSWIRE) -- The space-saving yet full-function video spectral comparator Regula 4306 has been deployed at Wattay International Airport in Vientiane, the Lao People’s Democratic Republic, to strengthen the country’s …
FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
GlobeNewswire
·
April 15, 2025
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major advancement in vascularized tissue engineering. A newly published study in ACS Biomaterials …
LyondellBasell renforce son leadership en matière de durabilité dans son Rapport sur le développement durable 2024 : From Vision to Value (De la vision à la valeur)
GlobeNewswire
·
April 15, 2025
HOUSTON, 15 avr. 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE : LYB), l’un des leaders mondiaux de l’industrie chimique, a publié aujourd’hui son Rapport sur le développement durable 2024, démontrant des progrès significatifs en matière de solutions …
LyondellBasell avança na liderança em sustentabilidade no Relatório de Sustentabilidade de 2024: Da Visão ao Valor
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- A LyondellBasell (NYSE: LYB), líder global na indústria química, divulgou hoje seu Relatório de Sustentabilidade de 2024, demonstrando progresso significativo em soluções circulares e de baixo carbono, ação …
LyondellBasell rafforza la leadership in materia di sostenibilità con il suo Rapporto di Sostenibilità 2024: “From Vision to Value”
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), leader globale nell'industria chimica, ha pubblicato oggi il suo Rapporto sulla Sostenibilità 2024, confermando progressi significativi nell’ambito delle soluzioni circolari e a basse …
LyondellBasell versterkt duurzaam leiderschap in Duurzaamheidsrapport 2024: van visie naar waarde
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), een leider in de wereldwijde chemische industrie, heeft vandaag zijn duurzaamheidsrapport van 2024 gepubliceerd, waarin staat dat er aanzienlijke vooruitgang is geboekt in circulaire …